Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs

<< Previous

Bullboard Posts

Next >>

Post by ama21968on Oct 05, 2010 8:25pm

341 Views

Post# 17532663

Pinetree bought 1 Million Halo shares

The TSX Venture Exchange has accepted for filing documentation with respect to the first tranche of a non-brokered private placement announced Sept. 29, 2010, and amended on Oct. 1, 2010.

Number of shares: One million shares

Purchase price: 25 cents per share

Warrants: One million share purchase warrants to purchase one million shares

Warrant exercise price: 35 cents for a two-year period

Insider: Pinetree Resource Partnership, one million

<< Previous

Bullboard Posts

Next >>

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!